BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9853519)

  • 1. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors.
    Fan DS; Ogawa M; Fujimoto KI; Ikeguchi K; Ogasawara Y; Urabe M; Nishizawa M; Nakano I; Yoshida M; Nagatsu I; Ichinose H; Nagatsu T; Kurtzman GJ; Ozawa K
    Hum Gene Ther; 1998 Nov; 9(17):2527-35. PubMed ID: 9853519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
    Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
    Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotransduction of tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes into cultured striatal cells using adeno-associated virus vectors.
    Fan D; Kang D; Ogawa M; Nakano I; Nagatsu T; Kurtzman GJ; Ozawa K
    Chin Med J (Engl); 1998 Dec; 111(12):1111-3. PubMed ID: 11263376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes.
    Muramatsu S; Fujimoto K; Ikeguchi K; Shizuma N; Kawasaki K; Ono F; Shen Y; Wang L; Mizukami H; Kume A; Matsumura M; Nagatsu I; Urano F; Ichinose H; Nagatsu T; Terao K; Nakano I; Ozawa K
    Hum Gene Ther; 2002 Feb; 13(3):345-54. PubMed ID: 11860702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
    Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
    Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
    Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus vector-mediated triple gene transfer of dopamine synthetic enzymes.
    Fan D; Shen Y; Kang D; Nakano I; Ozawa K
    Chin Med J (Engl); 2001 Dec; 114(12):1276-9. PubMed ID: 11793852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease.
    Azzouz M; Martin-Rendon E; Barber RD; Mitrophanous KA; Carter EE; Rohll JB; Kingsman SM; Kingsman AJ; Mazarakis ND
    J Neurosci; 2002 Dec; 22(23):10302-12. PubMed ID: 12451130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.
    Sánchez-Pernaute R; Harvey-White J; Cunningham J; Bankiewicz KS
    Mol Ther; 2001 Oct; 4(4):324-30. PubMed ID: 11592835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
    Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
    J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors.
    Ozawa K; Fan DS; Shen Y; Muramatsu S; Fujimoto K; Ikeguchi K; Ogawa M; Urabe M; Kume A; Nakano I
    J Neural Transm Suppl; 2000; (58):181-91. PubMed ID: 11128607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.
    Ciesielska A; Sharma N; Beyer J; Forsayeth J; Bankiewicz K
    PLoS One; 2015; 10(4):e0122708. PubMed ID: 25860990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene therapy of tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and GTP cyclohydrolase genes in rat model of Parkinson's disease].
    Lu LL; Su Y; Duan CL; Zhao CL; Su YJ; Wu J; Zhao HY; Xu QY; Yang H
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1528-32. PubMed ID: 15500713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral-mediated temporally controlled dopamine production in a rat model of Parkinson disease.
    Li XG; Okada T; Kodera M; Nara Y; Takino N; Muramatsu C; Ikeguchi K; Urano F; Ichinose H; Metzger D; Chambon P; Nakano I; Ozawa K; Muramatsu S
    Mol Ther; 2006 Jan; 13(1):160-6. PubMed ID: 16182609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector.
    Sun M; Zhang GR; Kong L; Holmes C; Wang X; Zhang W; Goldstein DS; Geller AI
    Hum Gene Ther; 2003 Mar; 14(5):415-24. PubMed ID: 12691607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats.
    Sanftner LM; Rivera VM; Suzuki BM; Feng L; Berk L; Zhou S; Forsayeth JR; Clackson T; Cunningham J
    Mol Ther; 2006 Jan; 13(1):167-74. PubMed ID: 16126007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene therapy for Parkinson's disease: studies in animal models].
    Muramatsu S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1157-9. PubMed ID: 12235825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.
    Wang L; Wang Z; Zhu R; Bi J; Feng X; Liu W; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
    PLoS One; 2017; 12(6):e0179476. PubMed ID: 28622392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector.
    During MJ; Samulski RJ; Elsworth JD; Kaplitt MG; Leone P; Xiao X; Li J; Freese A; Taylor JR; Roth RH; Sladek JR; O'Malley KL; Redmond DE
    Gene Ther; 1998 Jun; 5(6):820-7. PubMed ID: 9747462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.
    Kaplitt MG; Leone P; Samulski RJ; Xiao X; Pfaff DW; O'Malley KL; During MJ
    Nat Genet; 1994 Oct; 8(2):148-54. PubMed ID: 7842013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.